Safety of perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: An interim safety analysis of the DANTE, a randomized, open-label phase II trial of the German Gastric Group at the AIO and the SAKK.

Salah‐Eddin Al‐Batran, Nils Homann, Michael Schenk et al.|Journal of Clinical Oncology|2020

Cited by 6